Webvent

WEF Buyers Guide

Access the most comprehensive, interactive directory of solutions providers for water professionals. Find your next solution on WEF Buyer's Guide - now owned and operated by WEF!

Treatment of Pharmaceutical Wastewaters to Reduce API Risks

Wednesday, April 17, 2024 12:00pm - 12:45pm EDT  
Host: WEF Buyers Guide
By: Dave Riedel, Principal Engineer, Arcadis and Ed Helmig, Principal Engineer, Arcadis

This presentation includes a brief overview of antibiotics and highlights the common mechanisms of antimicrobial resistance. A discussion of the manufacturing unit processes and key waste streams are presented along with sampling and analytical challenges. The widely accepted risk quantification methodology is briefly described. Finally, we present several proven treatment technologies, based on our bench, pilot and full-scale experience.

Registration

This Webinar has ended, but you can view its content in the archive below.
Please sign in, or enter the following to view the content archive:

Archive

Please register above to view this Webinar.

Presenters

Dave Riedel
Dave Riedel

Principal Engineer, Arcadis

Dave has broad experience in solving wastewater-related problems for municipalities and industries, especially in the Life Science sector. He has extensive experience evaluating facility discharges within Pharmaceuticals in the Environment (PiE) assessment frameworks and developing treatment solutions to reduce active pharmaceutical ingredient (API) discharges to the environment. He has supported the design and construction of multiple advanced treatment systems to address PiE concerns and has participated in factory acceptance tests for ozone and biokill systems in support of these projects.


Ed Helmig
Ed Helmig

Principal Engineer, Arcadis

Ed Helmig is a Principal Engineer at Arcadis and has 40 years’ experience as an Environmental Engineer and Water & Wastewater Subject Matter Expert (SME). At Wyeth Pharmaceuticals Ed led the design and capital projects for 12 major wastewater treatment systems and dozens of studies totaling over $300M. Among his accomplishments Ed led the team that developed, designed, and demonstrated the first industrial wastewater treatment system in the world specifically designed and proven capable of removing a broad range of active pharmaceutical ingredients (API’s) to non-detectable levels or <1 part per trillion. Ed has authored twenty-two technical papers and delivered technical solutions to manufacturing sites in 27 different countries around the world. Ed has a BS in Environmental Engineering from Temple University where he is also a founding member of the Water Environment Technology (WET) Center that specializes in analytical methods and treatment technology for difficult wastewaters including those containing fluorinated organics (PFAS/PFOA).